• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Kancera

Less than 1K followers
Overview
Investor consensus
All
Webcasts
Press releases
ShowingAll content types

Press release2026-07-16 10:40

Novakand Pharma ger operationell uppdatering angående ledning, hemsida och planerad extra bolagsstämma

Kancera
Press release2026-07-16 10:40

Novakand Pharma Provides an Operational Update Regarding Management, Website, and Planned Extraordinary General Meeting

Kancera
Press release2026-06-25 15:00

Novakand Pharma kraftsamlar för utveckling av särläkemedel mot cancer

Kancera

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-06-25 15:00

Novakand Pharma consolidates forces for the development of orphan drugs against cancer

Kancera
Regulatory press release2026-05-26 14:00

Kommuniké från årsstämma i Novakand Pharma AB den 25 maj 2026

Kancera
Regulatory press release2026-04-24 11:00

Novakand Pharmas årsredovisning och bolagsstyrningsrapport för 2025 offentliggjord

Kancera
Regulatory press release2026-04-22 17:30

KALLELSE TILL ÅRSSTÄMMA I NOVAKAND PHARMA AB

Kancera
Regulatory press release2026-04-15 18:30

Kommuniké från extra bolagsstämma i Novakand Pharma AB den 15 april 2026

Kancera
Regulatory press release2026-04-14 09:00

Novakand Pharma övergår till halvårsrapportering

Kancera
Press release2026-03-31 08:00

Novakand Pharma kallar till extra bolagsstämma i syfte att fatta beslut om den framtida verksamhetsinriktningen – Kommentarer från styrelsen

Kancera
Press release2026-03-31 08:00

Novakand Pharma to hold Extraordinary General Meeting to decide on future business direction – Comments from the board of directors

Kancera
Regulatory press release2026-03-30 19:30

KALLELSE TILL EXTRA BOLAGSSTÄMMA I NOVAKAND PHARMA AB

Kancera
Regulatory press release2026-03-26 11:45

Nasdaq beslutar om avnotering av Novakand Pharma från First North Growth Market

Kancera
Regulatory press release2026-03-18 12:30

Novakand Pharma förlänger anställningen av VD Peter Selin och informerar om planerade extra bolagsstämmor

Kancera
Press release2026-03-02 07:00

Novakands styrelse föreslår ny verksamhetsinriktning och omlistning som kommer att framläggas på extra bolagsstämma

Kancera
Press release2026-03-02 07:00

Novakand’s Board of Directors proposes new business direction and relisting to be presented at Extraordinary General Meeting

Kancera
Regulatory press release2026-02-27 15:00

Novakand Pharma informerar aktieägarna om att den extra bolagsstämman den 12 mars 2026 ställs in

Kancera
Press release2026-02-25 16:45

The board evaluates Novakand Pharma’s options after the decision not to execute the planned reverse take over of SVF Vaccines

Kancera
Press release2026-02-25 16:45

Styrelsen utvärderar Novakand Pharmas handlingsalternativ efter beslutet att det planerade omvända förvärvet av SVF Vaccines ej genomförs

Kancera
Regulatory press release2026-02-24 13:15

Novakand Pharma rapporterar att det planerade omvända förvärvet av SVF Vaccines inte kommer genomföras sedan Nasdaq avslagit ansökan om en fortsatt notering av det sammanslagna bolaget

Kancera